25 March 2021

Wout Feitz and colleagues, theme Reconstructive & Regenerative Medicine, publish an article in European Urology, which provides an overview and identifies challenges in collecting data at the European level from the ERN eUROGEN patient population.

Background 

In 2017, the European Commission launched 24 thematic European Reference Networks (ERNs). Radboudumc participates in 14 networks and two of these networks are coordinated by Radboudumc: ERN GENTURIS and ERN eUROGEN.

ERN eUROGEN is the network for urorectogenital diseases and complex conditions, and started with 29 full member healthcare providers (HCPs) in 11 countries. It then covered 19 different disease areas distributed over three workstreams (WSs).

Objective

To provide an overview and identify challenges in data collection at European level of the ERN eUROGEN patient population treated by HCPs in the network.

Design, setting, and participants

A retrospective cohort study was conducted of the 29 HCPs who were full members between 2013 and 2019.

Outcome measurements and statistical analysis: Data were extracted from the original HCP applications and the ERN continuous monitoring system. Patient volumes, new patient numbers, and procedures were compared between different WSs, countries, and HCPs. Discrepancies between monitoring and application data were identified.

Results and limitations

Between 2013 and 2019, 122 040 patients required long-term care within the 29 HCPs. The volume of patients treated and procedures undertaken per year increased over time. Large discrepancies were found between patient numbers contained in the application forms and those reported in the continuous monitoring system (0-1357% deviation).

Conclusions

Patient numbers and procedures increased across ERN eUROGEN HCPs. Reliable data extraction appeared challenging, illustrated by the patient volume discrepancies between application forms and the continuous monitoring data. Improved disease definitions, re-evaluation of affiliated HCPs, and valid data extraction are needed for future improvements.

read more

ERN info in Dutch

Related news items


Self-healing injectable hydrogels: an emerging class of novel biomaterials

30 August 2022

Researchers from Radboudumc and Harvard University have jointly published a review article on self-healing injectable hydrogels in Chemical Reviews.

read more

Vote for the RIMLS Supervisor of the year

7 December 2021

This is your chance to vote for your favourite candidate for supervisor of the year! Support and promote your ideal supervisor from the three nominees: Siroon Bekkering, Gerald Verhaegh and Jo Zhou. Please submit your vote the 20th of December 2021 at the latest.

read more

Willeke Daamen ratified as ETRS board member

3 November 2021 Willeke Daamen, theme Reconstructive and regenerative medicine appointed as board member of The European Tissue Repair Society (ETRS). read more

RIMLS awards call for nominations

19 October 2021 RIMLS awards several prizes to stimulate and honor our (young) researchers. Upcoming awards are Supervisor of the Year, Best Master Thesis, Best Publication, Best Image and more. Send your nominations now before 24 November 2021. read more

Turbo Grants for four medical-technical research projects

19 October 2021 Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc. read more

Best presentation award for Felicitas Pardow at the European Epidermal Barrier Research Network

28 September 2021 During the annual meeting of the European Epidermal Barrier Research Network (E2BRN) recently, Felicitas Pardow received the best presentation award. read more